TY - JOUR
T1 - Myotube protein content associates with intracellular L-glutamine levels
AU - De Vasconcelos, Diogo Antonio Alves
AU - Giesbertz, Pieter
AU - Murata, Gilson Masahiro
AU - De Souza, Diego Ribeiro
AU - Fiamoncini, Jarlei
AU - Duque-Guimaraes, Daniella
AU - Leandro, Carol Góis
AU - Hirabara, Sandro Massao
AU - Daniel, Hannelore
AU - Curi, Rui
AU - Pithon-Curi, Tania Cristina
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019
Y1 - 2019
N2 - Background/Aims: Skeletal mass loss is reported in several catabolic conditions and it has been associated with a reduced intracellular L-glutamine content. We investigated the association of intracellular L-glutamine concentration with the protein content in skeletal muscle cells. Methods: We cultivated C2C12 myotubes in the absence or presence of 2 (reference condition), 8 or 16 mM L-glutamine for 48 hours, and the variations in the contents of amino acids and proteins measured. We used an inhibitor of L-glutamine synthesis (L-methionine sulfoximine-MSO) to promote a further reduction in intracellular L-glutamine levels. Amino acids contents in cells and media were measured using LC-MS/MS. We measured changes in phosphorylated Akt, RP-S6, and 4E-BP1contents in the absence or presence of insulin by western blotting. Results: Reduced intracellular L-glutamine concentration was associated with decreased protein content and increased protein breakdown. Low intracellular glutamine levels were also associated with decreased p-Akt contents in the presence of insulin. A further decrease in intracellular L-glutamine caused by glutamine synthetase inhibitor reduced protein content and levels of amino acids generated from glutamine metabolism and increased bAib still further. Cells exposed to high medium glutamine levels did not have any change in protein content but exhibited increased contents of the amino acids derived from L-glutamine metabolism. Conclusion: Intracellular L-glutamine levels per se play a role in the control of protein content in skeletal muscle myotubes.
AB - Background/Aims: Skeletal mass loss is reported in several catabolic conditions and it has been associated with a reduced intracellular L-glutamine content. We investigated the association of intracellular L-glutamine concentration with the protein content in skeletal muscle cells. Methods: We cultivated C2C12 myotubes in the absence or presence of 2 (reference condition), 8 or 16 mM L-glutamine for 48 hours, and the variations in the contents of amino acids and proteins measured. We used an inhibitor of L-glutamine synthesis (L-methionine sulfoximine-MSO) to promote a further reduction in intracellular L-glutamine levels. Amino acids contents in cells and media were measured using LC-MS/MS. We measured changes in phosphorylated Akt, RP-S6, and 4E-BP1contents in the absence or presence of insulin by western blotting. Results: Reduced intracellular L-glutamine concentration was associated with decreased protein content and increased protein breakdown. Low intracellular glutamine levels were also associated with decreased p-Akt contents in the presence of insulin. A further decrease in intracellular L-glutamine caused by glutamine synthetase inhibitor reduced protein content and levels of amino acids generated from glutamine metabolism and increased bAib still further. Cells exposed to high medium glutamine levels did not have any change in protein content but exhibited increased contents of the amino acids derived from L-glutamine metabolism. Conclusion: Intracellular L-glutamine levels per se play a role in the control of protein content in skeletal muscle myotubes.
KW - Amino acids
KW - Glutamine metabolism
KW - Protein breakdown
KW - Skeletal muscle cells
KW - β-aminoisobutyric acid
UR - http://www.scopus.com/inward/record.url?scp=85069304472&partnerID=8YFLogxK
U2 - 10.33594/000000130
DO - 10.33594/000000130
M3 - Article
C2 - 31287628
AN - SCOPUS:85069304472
SN - 1015-8987
VL - 53
SP - 200
EP - 214
JO - Cellular Physiology and Biochemistry
JF - Cellular Physiology and Biochemistry
IS - 1
ER -